ZGNX Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2022-03-07 | Smith Michael P | officer: EVP, CFO & Treasurer | 0 | D-Return | D | 35,499 | 0.00 | 0.00 |
| 2022-03-07 | Smith Michael P | officer: EVP, CFO & Treasurer | 0 | D-Return | D | 35,499 | 0.00 | 0.00 |
| 2022-03-07 | Smith Michael P | officer: EVP, CFO & Treasurer | 0 | U-Tender | D | 8,016 | 0.00 | 0.00 |
| 2022-03-07 | WIGGINS MARK C | director | 0 | D-Return | D | 22,000 | 17.83 | 392,260.00 |
| 2022-03-07 | WIGGINS MARK C | director | 0 | U-Tender | D | 2,500 | 0.00 | 0.00 |
| 2022-03-07 | Stutts Mary E. | director | 0 | D-Return | D | 22,000 | 17.83 | 392,260.00 |
| 2022-03-07 | BREITMEYER JAMES B | director | 0 | D-Return | D | 22,000 | 17.83 | 392,260.00 |
| 2022-03-07 | BREITMEYER JAMES B | director | 0 | U-Tender | D | 1,250 | 0.00 | 0.00 |
| 2022-03-07 | TANNENBAUM RENEE P | director | 0 | D-Return | D | 22,000 | 17.83 | 392,260.00 |
| 2022-03-07 | TANNENBAUM RENEE P | director | 0 | U-Tender | D | 32,567 | 0.00 | 0.00 |
| 2022-03-07 | BOCK LOUIS C | director | 0 | D-Return | D | 22,000 | 17.83 | 392,260.00 |
| 2022-03-07 | MAST ERLE T | director | 0 | D-Return | D | 22,000 | 17.83 | 392,260.00 |
| 2022-03-07 | MAST ERLE T | director | 0 | U-Tender | D | 3,027 | 0.00 | 0.00 |
| 2022-03-07 | Farfel Gail M | officer: EVP & Chief Development Officer | 0 | D-Return | D | 40,187 | 0.00 | 0.00 |
| 2022-03-07 | Farfel Gail M | officer: EVP & Chief Development Officer | 0 | D-Return | D | 40,187 | 0.00 | 0.00 |
| 2022-03-07 | Farfel Gail M | officer: EVP & Chief Development Officer | 0 | U-Tender | D | 16,606 | 0.00 | 0.00 |
| 2022-03-07 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 45,499 | 0.00 | 0.00 |
| 2022-03-07 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 45,499 | 0.00 | 0.00 |
| 2022-03-07 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | U-Tender | D | 25,022 | 0.00 | 0.00 |
| 2022-03-07 | Mitchell Shawnte | officer: EVP, GC & Secretary | 0 | D-Return | D | 25,000 | 0.00 | 0.00 |
| 2022-03-07 | Mitchell Shawnte | officer: EVP, GC & Secretary | 0 | D-Return | D | 25,000 | 0.00 | 0.00 |
| 2022-03-07 | Mitchell Shawnte | officer: EVP, GC & Secretary | 0 | U-Tender | D | 605 | 0.00 | 0.00 |
| 2022-03-07 | GARNER CAM L | director | 0 | D-Return | D | 22,000 | 17.83 | 392,260.00 |
| 2022-03-07 | GARNER CAM L | director | 0 | U-Tender | D | 40,843 | 0.00 | 0.00 |
| 2022-03-07 | Loewy Caroline M | director | 0 | D-Return | D | 22,000 | 17.83 | 392,260.00 |
| 2022-03-07 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 128,955 | 0.00 | 0.00 |
| 2022-03-07 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 128,955 | 0.00 | 0.00 |
| 2022-03-07 | FARR STEPHEN J | director, officer: President & CEO | 0 | U-Tender | D | 92,806 | 0.00 | 0.00 |
| 2022-03-07 | Sagrolikar Ashish M | officer: EVP & Chief Operating Officer | 0 | D-Return | D | 75,312 | 0.00 | 0.00 |
| 2022-03-07 | Sagrolikar Ashish M | officer: EVP & Chief Operating Officer | 0 | D-Return | D | 75,312 | 0.00 | 0.00 |
| 2022-03-07 | Sagrolikar Ashish M | officer: EVP & Chief Operating Officer | 0 | U-Tender | D | 17,156 | 0.00 | 0.00 |
| 2022-03-07 | Waynick Denelle J | director | 0 | D-Return | D | 22,000 | 17.83 | 392,260.00 |
| 2022-03-07 | Waynick Denelle J | director | 0 | U-Tender | D | 584 | 0.00 | 0.00 |
| 2022-02-01 | MAST ERLE T | director | 0 | M-Exempt | D | 1,250 | 12.00 | 15,000.00 |
| 2022-02-01 | MAST ERLE T | director | 3,027 | S-Sale | D | 1,250 | 26.04 | 32,544.50 |
| 2022-02-01 | MAST ERLE T | director | 4,277 | M-Exempt | A | 1,250 | 12.00 | 15,000.00 |
| 2022-01-19 | MAST ERLE T | director | 1,250 | M-Exempt | D | 4,375 | 12.00 | 52,500.00 |
| 2022-01-19 | MAST ERLE T | director | 0 | M-Exempt | D | 4,375 | 14.88 | 65,100.00 |
| 2022-01-19 | MAST ERLE T | director | 3,027 | S-Sale | D | 15,000 | 26.09 | 391,296.00 |
| 2022-01-19 | MAST ERLE T | director | 18,027 | M-Exempt | A | 4,375 | 12.00 | 52,500.00 |
| 2022-01-19 | MAST ERLE T | director | 13,652 | M-Exempt | A | 4,375 | 14.88 | 65,100.00 |
| 2022-01-19 | MAST ERLE T | director | 9,277 | M-Exempt | A | 6,250 | 15.04 | 94,000.00 |
| 2021-11-29 | TANNENBAUM RENEE P | director | 32,567 | S-Sale | D | 5,305 | 11.72 | 62,174.60 |
| 2021-08-10 | GARNER CAM L | director | 41,000 | P-Purchase | A | 10,000 | 14.83 | 148,298.00 |
| 2021-08-09 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2021-08-09 | Sagrolikar Ashish M | officer: EVP & CHIEF COMMERCIAL OFFICER | 20,000 | A-Award | A | 20,000 | 14.86 | 297,200.00 |
| 2021-08-09 | Sagrolikar Ashish M | officer: EVP & CHIEF COMMERCIAL OFFICER | 10,000 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2021-07-02 | Sagrolikar Ashish M | officer: EVP & CHIEF COMMERCIAL OFFICER | 17,259 | M-Exempt | A | 3,500 | 0.00 | 0.00 |
| 2021-07-02 | Sagrolikar Ashish M | officer: EVP & CHIEF COMMERCIAL OFFICER | 16,145 | F-InKind | D | 1,114 | 17.74 | 19,762.36 |
| 2021-07-02 | Sagrolikar Ashish M | officer: EVP & CHIEF COMMERCIAL OFFICER | 3,750 | M-Exempt | D | 3,750 | 0.00 | 0.00 |
| 2021-06-01 | Waynick Denelle J | director | 584 | P-Purchase | A | 584 | 17.07 | 9,968.88 |
| 2021-06-01 | TANNENBAUM RENEE P | director | 37,872 | P-Purchase | A | 5,000 | 17.05 | 85,247.50 |
| 2021-05-27 | Stutts Mary E. | director | 22,000 | A-Award | A | 22,000 | 17.83 | 392,260.00 |
| 2021-05-27 | BOCK LOUIS C | director | 22,000 | A-Award | A | 22,000 | 17.83 | 392,260.00 |
| 2021-05-27 | MAST ERLE T | director | 22,000 | A-Award | A | 22,000 | 17.83 | 392,260.00 |
| 2021-05-27 | Loewy Caroline M | director | 22,000 | A-Award | A | 22,000 | 17.83 | 392,260.00 |
| 2021-05-27 | TANNENBAUM RENEE P | director | 22,000 | A-Award | A | 22,000 | 17.83 | 392,260.00 |
| 2021-05-27 | BREITMEYER JAMES B | director | 22,000 | A-Award | A | 22,000 | 17.83 | 392,260.00 |
| 2021-05-27 | Waynick Denelle J | director | 22,000 | A-Award | A | 22,000 | 17.83 | 392,260.00 |
| 2021-05-27 | GARNER CAM L | director | 22,000 | A-Award | A | 22,000 | 17.83 | 392,260.00 |
| 2021-05-27 | WIGGINS MARK C | director | 22,000 | A-Award | A | 22,000 | 17.83 | 392,260.00 |
| 2021-05-10 | GARNER CAM L | director | 31,000 | P-Purchase | A | 15,000 | 19.03 | 285,496.50 |
| 2021-03-26 | Smith Michael P | officer: EVP, CFO, Treasurer & Sec. | 25,000 | A-Award | A | 25,000 | 18.76 | 469,000.00 |
| 2021-03-26 | Smith Michael P | officer: EVP, CFO, Treasurer & Sec. | 12,500 | A-Award | A | 12,500 | 0.00 | 0.00 |
| 2021-03-26 | FARR STEPHEN J | director, officer: President and CEO | 93,335 | A-Award | A | 93,335 | 18.76 | 1,750,964.60 |
| 2021-03-26 | Mitchell Shawnte | officer: EVP, GC and Secretary | 25,000 | A-Award | A | 25,000 | 18.76 | 469,000.00 |
| 2021-03-26 | Mitchell Shawnte | officer: EVP, GC and Secretary | 12,500 | A-Award | A | 12,500 | 0.00 | 0.00 |
| 2021-03-26 | FARR STEPHEN J | director, officer: President and CEO | 46,665 | A-Award | A | 46,665 | 0.00 | 0.00 |
| 2021-03-26 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 30,000 | A-Award | A | 30,000 | 18.76 | 562,800.00 |
| 2021-03-26 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 15,000 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2021-03-26 | Sagrolikar Ashish M | officer: EVP & CHIEF COMMERCIAL OFFICER | 25,000 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2021-03-26 | Sagrolikar Ashish M | officer: EVP & CHIEF COMMERCIAL OFFICER | 50,000 | A-Award | A | 50,000 | 18.76 | 938,000.00 |
| 2021-03-26 | Farfel Gail M | officer: EVP/Chief Development Officer | 30,000 | A-Award | A | 30,000 | 18.76 | 562,800.00 |
| 2021-03-26 | Farfel Gail M | officer: EVP/Chief Development Officer | 15,000 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2021-03-15 | FARR STEPHEN J | director, officer: President and CEO | 20,625 | M-Exempt | D | 6,875 | 0.00 | 0.00 |
| 2021-03-15 | FARR STEPHEN J | director, officer: President and CEO | 88,066 | M-Exempt | A | 5,000 | 0.00 | 0.00 |
| 2021-03-15 | FARR STEPHEN J | director, officer: President and CEO | 5,000 | M-Exempt | D | 5,000 | 0.00 | 0.00 |
| 2021-03-15 | FARR STEPHEN J | director, officer: President and CEO | 84,795 | M-Exempt | A | 5,000 | 0.00 | 0.00 |
| 2021-03-15 | FARR STEPHEN J | director, officer: President and CEO | 83,066 | F-InKind | D | 1,729 | 20.70 | 35,790.30 |
| 2021-03-15 | FARR STEPHEN J | director, officer: President and CEO | 86,337 | F-InKind | D | 1,729 | 20.70 | 35,790.30 |
| 2021-03-15 | FARR STEPHEN J | director, officer: President and CEO | 93,212 | M-Exempt | A | 6,875 | 0.00 | 0.00 |
| 2021-03-15 | FARR STEPHEN J | director, officer: President and CEO | 90,834 | F-InKind | D | 2,378 | 20.70 | 49,224.60 |
| 2021-03-15 | FARR STEPHEN J | director, officer: President and CEO | 15,000 | M-Exempt | D | 5,000 | 0.00 | 0.00 |
| 2021-03-15 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 19,171 | F-InKind | D | 438 | 20.70 | 9,066.60 |
| 2021-03-15 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 21,202 | M-Exempt | A | 2,031 | 0.00 | 0.00 |
| 2021-03-15 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 20,633 | F-InKind | D | 569 | 20.70 | 11,778.30 |
| 2021-03-15 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 22,258 | M-Exempt | A | 1,625 | 0.00 | 0.00 |
| 2021-03-15 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 21,803 | F-InKind | D | 455 | 20.70 | 9,418.50 |
| 2021-03-15 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 1,562 | M-Exempt | D | 1,562 | 0.00 | 0.00 |
| 2021-03-15 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 4,062 | M-Exempt | D | 2,031 | 0.00 | 0.00 |
| 2021-03-15 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 4,875 | M-Exempt | D | 1,625 | 0.00 | 0.00 |
| 2021-03-15 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 19,609 | M-Exempt | A | 1,562 | 0.00 | 0.00 |
| 2021-03-15 | Sagrolikar Ashish M | officer: EVP & CHIEF COMMERCIAL OFFICER | 11,588 | M-Exempt | A | 2,031 | 0.00 | 0.00 |
| 2021-03-15 | Sagrolikar Ashish M | officer: EVP & CHIEF COMMERCIAL OFFICER | 13,484 | M-Exempt | A | 2,500 | 0.00 | 0.00 |
| 2021-03-15 | Sagrolikar Ashish M | officer: EVP & CHIEF COMMERCIAL OFFICER | 12,741 | F-InKind | D | 743 | 20.70 | 15,380.10 |
| 2021-03-15 | Sagrolikar Ashish M | officer: EVP & CHIEF COMMERCIAL OFFICER | 4,062 | M-Exempt | D | 2,031 | 0.00 | 0.00 |
| 2021-03-15 | Sagrolikar Ashish M | officer: EVP & CHIEF COMMERCIAL OFFICER | 7,500 | M-Exempt | D | 2,500 | 0.00 | 0.00 |
| 2021-03-15 | Sagrolikar Ashish M | officer: EVP & CHIEF COMMERCIAL OFFICER | 10,984 | F-InKind | D | 604 | 20.70 | 12,502.80 |
| 2021-03-15 | Farfel Gail M | officer: EVP/Chief Development Officer | 4,500 | M-Exempt | D | 1,500 | 0.00 | 0.00 |
| 2021-03-15 | Farfel Gail M | officer: EVP/Chief Development Officer | 13,109 | M-Exempt | A | 1,625 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.